MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Alternating thalamic deep brain stimulation for Essential Tremor: A trial to reduce habituation

    M. Seier, A. Hiller, J. Quinn, C. Murchison, M. Brodsky, S. Anderson (Omaha, NE, USA)

    Objective: We propose a novel approach to the treatment paradigm for deep brain stimulation (DBS) programming in the ventral intermediate nucleus (VIM) for patients with…
  • 2018 International Congress

    Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease

    H. Jeong, S. Chung, J. Oh, J. Kim, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the relationship between the sub-regional pattern of striatal dopamine depletion and cognitive impairment in early-stage Parkinson’s disease (PD), and determine the effect…
  • 2018 International Congress

    Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In this study, we aimed to investigate the neuroprotective effect of curcumin against rotenone-induced memory impairments in rat PD model. Background: In PD, oxidative…
  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2018 International Congress

    The development of an instrument for measuring Parkinson’s patient empowerment

    P. Viwattanakulvanid (Bangkok, Thailand)

    Objective: To develop a valid and reliable measurement scale of Parkinson’s patient empowerment index (PPEI). Background: Patient empowerment concept has been used as part of…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley